Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: levofloxacin oral solution
Total 0 results
Nothing found
Sponsors and Collaborators
GFI
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Agency for Science, Technology and Research
Everett Meyer
Alma Lasers Inc.
Hospital ASEPEYO Sant Cugat
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Neurophth Therapeutics Inc
Korean Society of Spine Surgery
Kupfer, David J., M.D.
iCAD
ASST Cremona, Cremona
Apollo Neuroscience, Inc.
Hospital Durand, Argentina
Eurofins Genoma
Aptis Medical
Nacuity Pharmaceuticals, Inc.
Mª Victoria Maestre Sanchez
RMIT University, Melbourne, Australia
View Full List
Medical Conditions
Splenic Trauma
Gastric Cancer Stage IIIB-IIIC
Fever
Luteal Phase Support
Metachronous Adenoma
Scleredema
Major Liver Surgery
Dienogest
Treatment Decisions
Recurrent Clear Cell Sarcoma of Soft Tissue
RISS Stage III Plasma Cell Myeloma
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Immune-Mediated Inflammatory Disease
Disorder of Fluid Balance
Corneal Cross-Linking
Rheumatoid Arthritis(RA)
The Strength Properties of the Aorta in Vitro
Chronic Constipation Symptoms
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
T-LGL Leukemia
View Full List
Drug Interventions
Oxycodone/acetaminophen 5/325 mg
Olopatadine
THC
Letrozole
MLN2480
Anticholinergic
GLPG1837 multiple ascending doses
TPN-101
Camptosar
Standard of care (SOC) for COVID-19
Intravenous Formulation of PD-0332991
Desvenlafaxine
PD-1/PD-L1 inhibitor
Capecitabine and IMRT (if randomized to this arm)
Fospropofol disodium, propofol
RDX227675
Capecitabine/cisplatin
Midazolam
OnabotulinumtoxinA
Intravenous deferiprone
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Australia
Contract Research Organizations in Benin
Contract Research Organizations in China
Contract Research Organizations in Finland
Contract Research Organizations in France
Contract Research Organizations in Hungary
Contract Research Organizations in Jordan
Contract Research Organizations in Lithuania
Contract Research Organizations in Mexico
Contract Research Organizations in Panama
Contract Research Organizations in Russia
Contract Research Organizations in Tanzania
CRO list by country
CROs in Liberia
SGS
FHI Clinical
All CROs in Liberia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe